Disease patterns · Advanced
EDX during an acute GBS course
Guillain–Barré syndrome
Early and follow-up findings may differ. One negative study must not stop clinical assessment.
01Clinical priorities
- Rapidly progressive weakness, reduced reflexes and respiratory, bulbar or autonomic involvement require immediate clinical attention.
- EDX supports diagnosis and classification but does not replace monitoring.
02Possible clues
- Abnormal late responses, nonuniform conduction abnormalities and sural sparing in some cases may help.
- AIDP, AMAN and AMSAN patterns can evolve with time and reversible conduction failure.
03Time matters
- Early studies may be nondiagnostic. Repeat testing should address a clinical question.
- Ongoing progression or relapse warrants reconsideration, including acute-onset CIDP.
Related nerves
Pause and explain
Explain in your own words: “Physiological classification may change over time; clinical needs come first.” Then think of a situation in which it could be misinterpreted.
Show a review prompt
A normal sural response or early normal NCS does not exclude GBS.
Check your understanding →
Progress stays in this browser. Marking a page as read is not a competency certification.
References and further reading
- EAN/PNS guideline on diagnosis and treatment of Guillain–Barré syndrome (2023) ↗EAN / PNS · Clinical guideline · Link accessed 2026-09-08
Educational synthesis; independent neuromuscular specialist review is pending. Publication dates and compilation dates are distinct. This is an original teaching synthesis; consult the source for complete methods and criteria.